435 related articles for article (PubMed ID: 30581068)
21. Biologics in the treatment of Sjogren's syndrome, systemic lupus erythematosus, and lupus nephritis.
Narain S; Berman N; Furie R
Curr Opin Rheumatol; 2020 Nov; 32(6):609-616. PubMed ID: 33002950
[TBL] [Abstract][Full Text] [Related]
22. Involvement of midkine in autoimmune and autoinflammatory diseases.
Aynacıoğlu AŞ; Bilir A; Tuna MY
Mod Rheumatol; 2019 Jul; 29(4):567-571. PubMed ID: 30217121
[TBL] [Abstract][Full Text] [Related]
23. Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients.
Pang M; Setoyama Y; Tsuzaka K; Yoshimoto K; Amano K; Abe T; Takeuchi T
Clin Exp Immunol; 2002 Jul; 129(1):160-8. PubMed ID: 12100036
[TBL] [Abstract][Full Text] [Related]
24. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
25. [The role of interleukin-12 in immune-mediated rheumatic diseases].
Spadaro A; Scrivo R; Rinaldi T; Riccieri V; Sili Scavalli A; Taccari E; Valesini G
Reumatismo; 2002; 54(2):113-21. PubMed ID: 12105679
[TBL] [Abstract][Full Text] [Related]
26. The weight of interleukin-6 in B cell-related autoimmune disorders.
Youinou P; Jamin C
J Autoimmun; 2009; 32(3-4):206-10. PubMed ID: 19307104
[TBL] [Abstract][Full Text] [Related]
27. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
[TBL] [Abstract][Full Text] [Related]
28. Functional affinity of IgM rheumatoid factor in patients with rheumatoid arthritis and other autoimmune diseases.
Rath S; Hogben DN; Devey ME
Ann Rheum Dis; 1988 Apr; 47(4):291-4. PubMed ID: 3365027
[TBL] [Abstract][Full Text] [Related]
29. Should rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases?
Galarza C; Valencia D; Tobón GJ; Zurita L; Mantilla RD; Pineda-Tamayo R; Rojas-Villarraga A; Rueda JC; Anaya JM
Clin Rev Allergy Immunol; 2008 Feb; 34(1):124-8. PubMed ID: 18270866
[TBL] [Abstract][Full Text] [Related]
30. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
31. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases.
Cravens PD; Lipsky PE
Immunol Cell Biol; 2002 Oct; 80(5):497-505. PubMed ID: 12225387
[TBL] [Abstract][Full Text] [Related]
32. Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials.
Deng Y; Wang Z; Chang C; Lu L; Lau CS; Lu Q
Hum Immunol; 2017 Feb; 78(2):120-128. PubMed ID: 28040536
[TBL] [Abstract][Full Text] [Related]
33. The role of microRNA-16 in the pathogenesis of autoimmune diseases: A comprehensive review.
Yan L; Liang M; Hou X; Zhang Y; Zhang H; Guo Z; Jinyu J; Feng Z; Mei Z
Biomed Pharmacother; 2019 Apr; 112():108583. PubMed ID: 30780103
[TBL] [Abstract][Full Text] [Related]
34. The autoimmune diseases.
Condemi JJ
JAMA; 1992 Nov; 268(20):2882-92. PubMed ID: 1433704
[No Abstract] [Full Text] [Related]
35. [New directions of pharmacotherapy of immune - inflammatory rheumatic diseases].
Nasonov EL
Ter Arkh; 2019 Aug; 91(8):98-107. PubMed ID: 32598760
[TBL] [Abstract][Full Text] [Related]
36. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
37. [Autoimmune disorders appearing in the mouth].
Malmström M
Proc Finn Dent Soc; 1983; 79(2):85-8. PubMed ID: 6889309
[No Abstract] [Full Text] [Related]
38. [Systemic autoimmune disorders and pregnancy].
Kiss E; Kiss CG; Poór G
Orv Hetil; 2011 Oct; 152(43):1715-23. PubMed ID: 21983397
[TBL] [Abstract][Full Text] [Related]
39. Clinical and immunological parameters of Sjögren's syndrome.
Psianou K; Panagoulias I; Papanastasiou AD; de Lastic AL; Rodi M; Spantidea PI; Degn SE; Georgiou P; Mouzaki A
Autoimmun Rev; 2018 Oct; 17(10):1053-1064. PubMed ID: 30103041
[TBL] [Abstract][Full Text] [Related]
40. CD5 B cells in autoimmunity.
Talal N; Dauphinee M; Ahmed SA
Ann N Y Acad Sci; 1992 May; 651():551-6. PubMed ID: 1376075
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
